Film star? Perfect Diary launches lipstick that can ‘reduce fine lines by over 50%’

The BioLip Essence Lipstick was described as “​the brand's first innovative lipstick product that combines lipstick makeup effects, lip essence functions and lip mask”.​

The lipstick features a pomegranate peptide complex, which the firm claims can “deeply plump the lip skin and make the lip skin glow with health and vitality”. ​The brand co-created the ingredient with a French R&D team, the firm said.

The effects of the ingredient are said to be boosted by the Biolip technology, which claims to form a protective barrier on the lips.

The efficacy of the lipstick has been verified by testing firm SGS and the Ruijin Hospital’s department of dermatology. Ruijin Hospital is a university hospital associated with Shanghai Jiao Tong University’s School of Medicine.

According to Zheng Jie, a tenured professor of Ruijin Hospital’s dermatology department, its clinical test showed that the BioLip Essence Lipstick could reduce the fine lips on the lips by 53.39% in two weeks.

The new lipstick aims to tap into the consumer demand for makeup with skin care benefits. The firm said it has observed growing demand for beauty products that have both makeup functions and “skin-nourishing effects”.​

Furthermore, the brand analysed 150,000 data sets on Asian skin to determine 12 shades that were the most suitable for East Asian skin tones.

Yatsen’s R&D focus

Perfect Diary’s latest lipstick innovation highlights the firm’s focus on R&D in both colour cosmetics and skin care.

The firm said that its development of a lipstick with skin care benefits aimed to boost consumer confidence in its products and research capabilities.

It noted that Chinese consumers were demanding higher quality, innovation, and value from their products.

CosmeticsDesign-Asia​ previously reported that Chinese consumers were becoming more discerning about their beauty purchase decisions.

“Consumer behaviour has shifted a little bit from previous impulsive buying habits toward more rational behaviour, which also kind of demonstrates that very strong efficacy and functional value actually probably attract more consumer attention and buying,” ​said Irene Lyu, vice President and head of strategic investments and capital markets, Yatsen.

According to Yatsen’s second-quarter (Q2) results, the firm invested 3% of its total revenues into R&D.

Huang Jinfeng, founder, chairman and CEO of Yatsen vowed that the firm would continue to invest in R&D and innovation.

In August, the company officially launched a new manufacturing hub in Guangzhou in partnership with South Korean cosmetics manufacturer Cosmax.

The launch of the new manufacturing facility followed the establishment of Yatsen Ruijin Medical skin care joint laboratory with the Shanghai Jiaotong University School of Medicine.

In Q2, the company’s total net revenues for the second quarter of 2023 decreased by 9.8% to RMB868.6m (USD118.4m). The 2.3% growth in skin care revenues failed to offset the the decline in colour cosmetic sales, which dropped 16.6% year on year.